Two players from Austria's Salzburg fail doping tests after Mali game

Topics Doping | football | Mali

Two players from Austrian champion Salzburg have failed doping tests after returning from international duty with Mali last month.

Midfielder Mohamed Camara and forward Sekou Koita reported being given medication for altitude sickness before an away game against Namibia on Nov. 17 in qualifying for the African Cup of Nations, Salzburg said on Tuesday.

They tested positive on Nov. 22 in Austria in UEFA testing ahead of a Champions League defeat to Bayern Munich, the club said.

Salzburg didn't name the banned substance in question but said it was "a key ingredient" in the altitude sickness medication the players were allegedly given.

Salzburg said it supports the players and wants to clear up what happened while the players were with the national team.

"We are very proud when our players are called up to their national teams. For a full international match, you have to expect though that medical work will conform to international standards, with doctors who are familiar with the rules," Salzburg general manager Stephan Reiter said in a statement.

Camara and Koita have played regularly for Salzburg since the date of the positive test.

UEFA did not immediately respond to a request for comment.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Business Standard is now on Telegram.
For insightful reports and views on business, markets, politics and other issues, subscribe to our official Telegram channel